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The first cause of low-dose acetylsalicylic-acid (ASA) inefficacy is poor adherence to
treatment. No non-invasive technique is available to assess ASA intake. Current-
induced vasodilation (CIV) was found abolished in healthy volunteers after low-dose
ASA intake. We tested clinical characteristics, treatments, and comorbid conditions
influencing CIV amplitude in vascular patients.
Methods
CIV was tested in 400 patients (277 males and 123 females, aged 65.4 ± 13.4 years).
We focused on clinical characteristics, treatments, and comorbid conditions as
covariates of CIV amplitude. We studied the CIV amplitude to covariate relationships
with multivariate linear regression and receiver operating characteristics (ROC).
Results
The multivariate linear model determined that ASA intake within the last 48 h and the
interaction between ASA intake and body mass index (BMI) were the sole covariates
associated with CIV amplitude. For the whole population, the area under the ROC
curve (AUC) for CIV to predict ASA intake was 0.853 [95% confidence interval (CI):
0.814–0.892]. Considering separately the areas observed for non-obese (BMI ≤30,
n = 303) and obese (BMI>30, n = 93) patients, the AUC [95% CI] was 0.873
[0.832–0.915] and 0.776 [0.675–0.878], respectively (p = 0.083).
Conclusions
ASA is the only drug that affects the amplitude of CIV response observed after
galvanic current application to the skin of vascular patients. CIV depends on BMI but
not age or gender. As such, CIV appears to be a potential objective marker of ASA
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